2024 MSK Pulmo-Oncology Symposium — On Demand

Thursday, October 31, 2024, 7:55 AM - Thursday, July 31, 2025, 11:00 PM

Pulmo-Oncology is an emerging discipline that has great importance to the clinical care of cancer patients. The respiratory system is often impacted by direct cancer involvement as well as by infections and toxicities stemming from the use of anti-neoplastic agents. Pre-existing pulmonary disorders affect patient outcomes and management decisions. Effective clinical management of pulmonary complications of cancer and its therapies requires an interdisciplinary approach.

This multidisciplinary symposium, originally held live on September 20, 2024, brought together clinical experts from Memorial Sloan Kettering Cancer Center (MSK) and leading institutions worldwide to deliver a comprehensive update on cutting-edge cancer therapies and best practices in evaluating and managing lung disease. The program features a state-of-the-art, case-based curriculum designed to address key topics critical to the respiratory health of cancer patients. For further information about this program and session topics, view the brochure from the live course.

1. Explain the role of the pulmonologist in diagnosis and management of lung cancer
2. Discuss multidisciplinary approach in complex patients
3. Identify state of the art treatment strategies for management of lung cancer and check point inhibitor pneumonitis
4. Implement strategies for diagnosis and management of infectious and non-infectious pulmonary complications of stem cell transplant
5. Explain the diagnosis and clinical significance of pre-existing interstitial lung abnormalities and interstitial lung disease in cancer management

Access to the course content requires registration. Once registered, all materials, including relevant financial disclosures and instructions for claiming credit, are located under the 'Course Content' tab. This on-demand program is available for purchase until April 30, 2025. For those that purchase this on demand, access to the content, as well as the opportunity to claim credit, is available through July 31, 2025. To enroll, please click the 'Register' tab at the top of the page.

Discounted registration is available for specific groups. If eligible, you will receive further instructions and a promotion code to use during registration. View our Policy on Registration Discounts for more information and to submit a request. Please note that after your payment has been processed, no further promotional discounts or adjustments will be made to your registration.

On Demand Access Fees
Physicians (MDs, PhDs, and DOs): $300
Advanced Practice Providers: $250
Nursing and Other Healthcare Professionals: $150
Residents, Fellows, and Students: $100
MSK Employees: Complimentary

This Memorial Sloan Kettering Continuing Medical Education on demand program is non-refundable.

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this enduring material for a maximum of 7.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

MOC/CC Recognition Statements

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to:

— 7.25 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program; and
— 7.25 credit toward the CME and Self-Assessment of the American Board of Thoracic Surgery’s (ABTS) Maintenance of Certification program.

It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM or ABTS MOC/CC credit.

Please be advised that MOC points will be awarded approximately 45 days after the submission of your evaluation.

Recorded/Review Date: September 20, 2024 | Original Release Date: October 31, 2024 | Termination Date: April 30, 2025

MSK Symposium Directors 

Leontine J.R. van Elden, MD, PhD
Associate Attending, Pulmonary Service;
Assistant Professor of Clinical Medicine
Weill Cornell Medical College

Elizabeth Yogiaveetil, MD
Assistant Attending, Pulmonary Service;
Assistant Professor of Clinical Medicine
Weill Cornell Medical College

Christina M. Hess, AGACNP-BC
Nurse Practitioner, Pulmonary Service


MSK Symposium Planning Committee

Mohit Chawla, MD, FCCP
Chief, Pulmonary Service

Kimia G. Ganjaei, MD
Fellow, Pulmonary and Critical Care Medicine Fellowship

Catherine Oberg, MD
Assistant Attending, Pulmonary Service

 

Invited Symposium Faculty 

Alexander I. Geyer, MD
Attending, Division of Pulmonary, Critical Care and Sleep Medicine
Lenox Hill Hospital
New York, NY, USA

Charles A. Powell, MD, MBA
Professor of Medicine;
System Division Chief for Pulmonary, Critical Care and Sleep Medicine
Icahn School of Medicine-Mount Sinai
New York, NY, USA

Ajay Sheshadri, MD, MSCI
Attending, Pulmonary Medicine
MD Anderson Cancer Center
Houston, TX, USA

Marcel Veltkamp, MD, PhD
Attending, Pulmonology 
St. Antonius Hospital Nieuwegein-ILD Center of Excellence
Nieuwegein, The Netherlands

 

MSK Faculty

Matthew Bott, MD
Associate Attending, Thoracic Surgery Service

Alissa J. Cooper, MD
Assistant Attending, Thoracic Oncology Service

Daniel Gomez, MD, MBA
Attending, External Beam Radiotherapy Service

Autumn C. Guyer, MD
Associate Attending; Clinical Director, Allergy/Immunology Service

Andrew Harris, MD
Associate Attending, Bone Marrow Transplant Service

Elena Mead, MD
Assistant Attending, Critical Care Medicine Service

Genovefa Papanicolaou, MD
Attending, Infectious Diseases Service

 

View relevant financial relationships as of the program date, September 20, 2024. 

Mitigation of Relevant Financial Relationships

Memorial Sloan Kettering Cancer Center adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others are required to disclose all financial relationships with ineligible companies (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity.